Many of you are following the ongoing effort by some political leaders to strip our scientific intellectual property rights pertaining to vaccines and treatments for COVID-19. This proprietary science and technology was developed by our scientists working day and night at great financial risk to our companies.
A diverse, global team of scientists, led by University College of London and Children’s National Hospital/George Washington University, has been selected for the final stages of Cancer Grand Challenges – and is in with a chance of securing a share of £80 million (c.$111 million) of funding to take on one of cancer’s toughest problems.
Nearly 170 teams submitted ideas for this round of awards, and the NGTC team, which stands for ‘Next Generation T-cell therapies for childhood cancers, led by Martin Pule, Ph.D., University College of London, and Catherine Bollard, M.B.Ch.B., M.D., Children’s National Hospital and George Washington University, is one of 11 shortlisted groups.
It is with enormous pride and excitement that we announce that Aifred Health is #2 in the WORLD in the Global @IBM Watson AI XPRIZE!
I could not be prouder of the entire Aifred Health team and especially the four co-Founders Robert Fratila, Kelly Perlman, Sonia Israel and David Benrimoh, MD.,CM., MSc. whose vision and passion started us on this journey.
The US$1M prize will be used to accelerate the delivery of our AI technology in the field of #depression and to begin the work to apply our tech to other disease indications where personalize treatment choice is needed to deliver better outcomes to patients.
UNITE, A comprehensive immuno-oncology approach
}https://www.youtube.com/watch?v=HmkDu4qK2aM
Three Surprising Lessons for Other Cities and Regions. Download the PDF: http://share.endeavor.org/pdf/HDSVBSV.pdf
The life sciences industry has been asked to play the lead role in delivering innovative solutions to the world’s pandemic challenges; but like other sectors, is not insulated from these disruptive societal and workplace impacts. And while far from finished, the industry is meeting the moment—delivering on biomedical innovations to mitigate and ultimately end the global pandemic; continuing its role as economic stalwart countering economic downturns with hiring and continued growth; adjusting to the turmoil of remote operations; advancing varied and creative diversity and inclusion initiatives; and partnering with educators to advance the science, technology, engineering, and math, or “STEM” talent needs of the industry as well as enhancing its diversity. This is a daunting agenda for any industry, let alone in a single year, and this report works to take stock of the industry’s position and strategic priorities in 2021, with a primary focus on its demands for workforce and talent, arguably the most critical ingredient for addressing this bold agenda.
TEDCO recently launched ‘TEDCO Talks’, a series featuring thought leaders in economic development across the State of Maryland. On May 28th, TEDCO CEO & Executive Director, Troy LeMaile-Stovall interviewed Sally Allain, Head of JLABS @ Washington DC, about the future of the innovation ecosystem and the crucial role that JLABS will play in advancing the BioHealth Capital Region. It was extremely uplifting to hear the leaders of the two powerhouses discuss solutions on issues ranging from pandemic preparedness and healthcare inequality to diversity in the workforce.
Coastal resources – including fish, minerals and energy – are critical to people, nature and the economy, and are a focus for the emerging sustainable blue economy agenda. It has long been recognized that a particular challenge in coastal areas is the management of land-based activities that generate detrimental impacts on coastal resources in the marine environment. Many of these pressures are negative externalities of land-based human activities that are not taken into account within existing resource-governance frameworks. Therefore, the development of improved approaches to land-sea governance that take account of how land-based activities affect the quality and availability of coastal resources is the focus of this report.
MaxCyte, a life science company specializing in cell-engineering technology, is relocating from Gaithersburg, Md., to Rockville, Md., Commercial Observer has learned.
The company signed a 13-year, 67,000-square-foot lease at 9713 Key West Avenue, a five-story, 120,000-square-foot office building, with landlord Beckham Gumbin Ventures.
Image: 9713 KEY WEST AVENUE. PHOTO: BY EDGE
2021 National SBIR Week kicks off in just 28 days! Taking place July 19 – July 23, the event will connect entrepreneurs working on advanced technologies to the country’s largest source of early stage funding – the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, which provide over $4 billion in funding to small businesses each year in a wide variety of technology areas. We want innovation to help all people, so we must get all people involved in creating those innovations!
